My Account Log in

1 option

Tamoxifen and breast cancer / Michael W. DeGregorio and Valerie J. Wiebe.

LIBRA RC280.B8 D39 1996
Loading location information...

Available from offsite location This item is stored in our repository but can be checked out.

Log in to request item
Format:
Book
Author/Creator:
DeGregorio, Michael W., 1955-
Contributor:
Wiebe, Valerie J., 1958-
Language:
English
Subjects (All):
Tamoxifen.
Breast--Cancer--Chemoprevention.
Breast.
Breast Neoplasms--drug therapy.
Tamoxifen--therapeutic use.
Cancer--Treatment.
Cancer.
Medical Subjects:
Breast Neoplasms--drug therapy.
Tamoxifen--therapeutic use.
Physical Description:
xi, 122 pages ; 21 cm
Edition:
Revised and updated edition.
Place of Publication:
New Haven, Conn. : Yale University Press, 1996.
Summary:
Tamoxifen is one of the most widely prescribed drugs used to prevent the recurrence of breast cancer. A nonsteroidal antiestrogen, it has been successful in treating postmenopausal women at nearly all stages of breast cancer. Despite its popularity, disturbing questions remain about the use of this drug. How effective is tamoxifen in treating patients who have hormone-insensitive breast tumors or who have not yet reached menopause? What are the potential risks in taking tamoxifen, and do they ever outweigh its benefits? Should tamoxifen be administered as a prophylactic drug for healthy premenopausal women who are at high risk of developing breast cancer? In this vitally important book, two leading scientific investigators present a balanced and accessible discussion of the diagnosis of breast cancer and the risks, benefits, and limitations of treatment alternatives, particularly tamoxifen. Michael W. DeGregorio and Valerie J. Wiebe discuss the history and evolution of tamoxifen as a treatment for breast cancer, explaining how it works, what its side effects are, and why tamoxifen treatment is unsuccessful for some women. They present the controversies surrounding the National Cancer Institute study of tamoxifen as a preventive for breast cancer, describing the hopes of the proponents of the study and the fears of its detractors (potential risks to women in the study include thrombosis, uterine cancer, and even breast cancer itself). The book is an invaluable aid to women faced with decisions about treatment or prevention of breast cancer.
Contents:
Common questions about breast cancer
Drug therapy
Tamoxifen and how it works
Tamoxifen in breast cancer
Side effects of tamoxifen
Tumor recurrence and tamoxifen resistance
Tamoxifen for prevention in healthy women
The ongoing controversy over the tamoxifen chemoprevention trial
Future approaches.
Notes:
"A Yale Fastback."
Includes bibliographical references (pages 105-113) and index.
ISBN:
0300059922
OCLC:
35690630

The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.

Find

Home Release notes

My Account

Shelf Request an item Bookmarks Fines and fees Settings

Guides

Using the Find catalog Using Articles+ Using your account